IBDEI1IQ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27266,0)
 ;;=305.00^^163^1695^2
 ;;^UTILITY(U,$J,358.3,27266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27266,1,4,0)
 ;;=4^305.00
 ;;^UTILITY(U,$J,358.3,27266,1,5,0)
 ;;=5^ALCOHOL ABUSE,UNSPEC
 ;;^UTILITY(U,$J,358.3,27266,2)
 ;;=^268227
 ;;^UTILITY(U,$J,358.3,27267,0)
 ;;=110.1^^163^1696^102
 ;;^UTILITY(U,$J,358.3,27267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27267,1,4,0)
 ;;=4^110.1
 ;;^UTILITY(U,$J,358.3,27267,1,5,0)
 ;;=5^ONYCHOMYCOSIS FINGER/TOE
 ;;^UTILITY(U,$J,358.3,27267,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,27268,0)
 ;;=278.00^^163^1696^97
 ;;^UTILITY(U,$J,358.3,27268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27268,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,27268,1,5,0)
 ;;=5^OBESITY
 ;;^UTILITY(U,$J,358.3,27268,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,27269,0)
 ;;=278.01^^163^1696^98
 ;;^UTILITY(U,$J,358.3,27269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27269,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,27269,1,5,0)
 ;;=5^OBESITY,MORBID
 ;;^UTILITY(U,$J,358.3,27269,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,27270,0)
 ;;=302.71^^163^1696^39
 ;;^UTILITY(U,$J,358.3,27270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27270,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,27270,1,5,0)
 ;;=5^DECREASE OF LIBIDO
 ;;^UTILITY(U,$J,358.3,27270,2)
 ;;=^331925
 ;;^UTILITY(U,$J,358.3,27271,0)
 ;;=305.00^^163^1696^18
 ;;^UTILITY(U,$J,358.3,27271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27271,1,4,0)
 ;;=4^305.00
 ;;^UTILITY(U,$J,358.3,27271,1,5,0)
 ;;=5^ALCOHOL ABUSE,UNSPEC
 ;;^UTILITY(U,$J,358.3,27271,2)
 ;;=^268227
 ;;^UTILITY(U,$J,358.3,27272,0)
 ;;=305.1^^163^1696^125
 ;;^UTILITY(U,$J,358.3,27272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27272,1,4,0)
 ;;=4^305.1
 ;;^UTILITY(U,$J,358.3,27272,1,5,0)
 ;;=5^TOBACCO USE DISORDER
 ;;^UTILITY(U,$J,358.3,27272,2)
 ;;=^119899
 ;;^UTILITY(U,$J,358.3,27273,0)
 ;;=305.90^^163^1696^119
 ;;^UTILITY(U,$J,358.3,27273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27273,1,4,0)
 ;;=4^305.90
 ;;^UTILITY(U,$J,358.3,27273,1,5,0)
 ;;=5^SUBSTANCE ABUSE
 ;;^UTILITY(U,$J,358.3,27273,2)
 ;;=^268258
 ;;^UTILITY(U,$J,358.3,27274,0)
 ;;=307.41^^163^1696^81
 ;;^UTILITY(U,$J,358.3,27274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27274,1,4,0)
 ;;=4^307.41
 ;;^UTILITY(U,$J,358.3,27274,1,5,0)
 ;;=5^INSOMNIA,NONORGANIC,TRANSIENT
 ;;^UTILITY(U,$J,358.3,27274,2)
 ;;=^268285
 ;;^UTILITY(U,$J,358.3,27275,0)
 ;;=368.9^^163^1696^128
 ;;^UTILITY(U,$J,358.3,27275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27275,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,27275,1,5,0)
 ;;=5^VISUAL DISTURBANCE NOS
 ;;^UTILITY(U,$J,358.3,27275,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,27276,0)
 ;;=389.9^^163^1696^64
 ;;^UTILITY(U,$J,358.3,27276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27276,1,4,0)
 ;;=4^389.9
 ;;^UTILITY(U,$J,358.3,27276,1,5,0)
 ;;=5^HEARING LOSS NOS
 ;;^UTILITY(U,$J,358.3,27276,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,27277,0)
 ;;=457.1^^163^1696^51
 ;;^UTILITY(U,$J,358.3,27277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27277,1,4,0)
 ;;=4^457.1
 ;;^UTILITY(U,$J,358.3,27277,1,5,0)
 ;;=5^EDEMA D/T LYMPHATIC OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,27277,2)
 ;;=^87693
 ;;^UTILITY(U,$J,358.3,27278,0)
 ;;=459.2^^163^1696^52
 ;;^UTILITY(U,$J,358.3,27278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27278,1,4,0)
 ;;=4^459.2
 ;;^UTILITY(U,$J,358.3,27278,1,5,0)
 ;;=5^EDEMA D/T VENOUS OBSTRUCTION
 ;;^UTILITY(U,$J,358.3,27278,2)
 ;;=^269850
 ;;^UTILITY(U,$J,358.3,27279,0)
 ;;=525.10^^163^1696^84
 ;;^UTILITY(U,$J,358.3,27279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,27279,1,4,0)
 ;;=4^525.10
